90% of CBD Brands Third-Party Test Their Products

1.8 min readPublished On: September 30th, 2021By

TUSTIN, Calif. –  While 84% of Americans are concerned about the CBD industry and its minimal level of regulatory oversight, most CBD products are third-party tested, according to an analysis conducted by industry watchdog CBD Oracle.

The study, which represents 520 CBD companies and 20,000 products in the United States and Europe, also shows a rise in certified-USDA Organic companies, indicating a higher level of self-regulation in an unregulated industry.

“Despite consumer apprehension being a huge problem, our analysis suggests an industry so conscious of its regulatory shortcomings; it’s taking appropriate steps to fix them,” says Alisdair Mans Cornwell, senior editor at CBD Oracle.

Third-party testing indicates a self-regulating industry. Testing evaluates CBD and THC levels, as well as the presence of pesticides, heavy metals, and solvents. 90% of CBD companies conduct independent, third-party testing on their products and publish all-important Certificates of Analysis (COAs) as proof. 25 companies are also certified USDA Organic, up by 24 since 2019.

“Third-party testing and USDA certifications aren’t required by law. It’s great to see companies taking the initiative to legitimize the industry, instill confidence in consumers, and ensure product safety and transparency despite the clear lack of federal oversight.”

However, celebrity-owned brands and companies selling CBD drinks are the least transparent. Mike Tyson’s Dwiink brand and Ivan Moody’s Moody’s Medicinals fail to provide extraction method, hemp source, or third-party testing information. Likewise, the majority of companies specializing in CBD drinks and beverages don’t disclose their extraction methods or third-party testing.

“The CBD industry certainly isn’t in the clear yet, but this analysis shows it’s doing way better than most expected,” Alisdair concludes.

About CBD Oracle: CBD Oracle is a California-based online magazine dedicated to improving safety, transparency, and quality of CBD and hemp products through independent company audits, market analysis, and product research. The company makes it its mission to provide expert advice to those who need it, publishing in-depth guides and product reviews, all backed by the latest scientific research. For more information, please visit cbdoracle.com.

(This information is primarily sourced from CBD Oracle.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

  • Ayr Wellness

Ayr Wellness Brings Cannabis Brand LIT To Massachusetts

August 4th, 2022|

MIAMI - Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF), a U.S. multi-state cannabis operator, announced that it has expanded its extensive branded-product portfolio with the flower brand, LIT. LIT originally launched in Nevada, produced by ...

PharmaCielo Announces First Shipment to Mexican Joint Venture Partner

August 4th, 2022|

TORONTO and RIONEGRO, Colombia–PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S.,  today announced its first shipment of ...